Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Connect Biopharma Holdings Ltd ADR (CNTB)

Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Connect Biopharma Holdings Ltd ADR 3580 CARMEL MOUNTAIN ROAD SUITE 200 SAN DIEGO CA 92130 USA

www.connectbiopharm.com Employees: 62 P: 877-245-2787 F: 858-614-7007

Sector:

Medical

Description:

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research. The company's product candidate includes CBP-201. Connect Biopharma Holdings Limited is based in TAICANG, China.

Key Statistics

Overview:

Market Capitalization, $K 150,382
Enterprise Value, $K 72,152
Shares Outstanding, K 55,904
Annual Sales, $ 26,030 K
Annual Net Income, $ -15,630 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -17,200 K
EBIT, $ -56,400 K
EBITDA, $ -55,740 K
60-Month Beta -0.19
% of Insider Shareholders 22.60%
% of Institutional Shareholders 58.72%
Float, K 43,270
% Float 77.40%
Short Interest 94
Short Float 0.17%
Short Volume Ratio 0.25

Growth:

1-Year Return 177.32%
3-Year Return 209.98%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/12/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -0.73
EPS Growth vs. Prev Qtr -34.78%
EPS Growth vs. Prev Year 641.67%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CNTB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -60.05%
Debt/Equity 0.00
Price/Sales 5.86
Price/Cash Flow N/A
Price/Book 2.76
Book Value/Share 0.99
Interest Coverage -0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar